pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

2,643 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT1184Endpoints903BioPharma Dive348BioSpace317Fierce Biotech301onclive165raps106globenewswire health
therapy area
allOncology7772Rare Disease1891Cardiology1780Immunology1512Hematology1329Vaccines1207Pulmonology
  • STAT reporter highlights diverse crowd and science at California longevity festival Vitalist Bay
    Alex Hogan of STAT introduces a video dispatch about Sarah Todd's recent visit to Vitalist Bay, a longevity festival held in California. Todd reports that the event defies the common image of long…
    STAT · 3mo agoNeutral↗ source
  • Axsome secures settlement to keep Sunosi exclusive until 2040
    Axsome Therapeutics announced it has reached a settlement that pushes back the entry of generic versions of its narcolepsy medication Sunosi until 2040. The agreement was reached with the last rem…
    Endpoints · 3mo agoRegulatoryPositive↗ source
← prev
page 82 of 106
next →
73
fda recalls70
fda medwatch60
fda press38
1203
Psychiatry & CNS870
Ophthalmology503
Pain483
Endocrinology & Metabolism481
Infectious Disease449
  • Alnylam inks up to $2 billion AI partnership with Inceptive Nucleics for RNAi drug discovery
    Alnylam announced a three-year strategic collaboration with Inceptive Nucleics to develop AI foundation models for RNAi therapeutics. The agreement is valued at up to $2 billion, with an initial $…
    STAT · 3mo agoDealPositive↗ source
  • Highmark Health sues HaloMD over alleged sham arbitration letter and misleading price data
    Highmark Health, a Pennsylvania Blue Cross Blue Shield licensee with more than 7 million members, filed a complaint on June 1 in U.S. District Court in Western Pennsylvania accusing HaloMD of abusi…
    STAT · 3mo agoRegulatoryNegative↗ source
  • Regeneron expands partnership with CytomX as other pharma partners exit
    Regeneron announced it will deepen its collaboration with CytomX Therapeutics, a Bay Area biotech. The decision follows CytomX losing several partnership agreements with other large pharmaceutical…
    Endpoints · 3mo agoDealPositive↗ source
  • Legend Biotech shares jump 40% after promising early CAR-T data in Non-Hodgkin’s lymphoma
    Shares of Legend Biotech rose more than 40% after the company released early results from its in vivo CAR‑T therapy targeting Non‑Hodgkin’s lymphoma. The data showed encouraging activity and a mana…
    STAT · 3mo agoPositive readoutPositive↗ source
  • Cigna to End Coverage of GLP-1 Weight-Loss Drugs Wegovy and Zepbound for Employees Starting July 1
    Cigna announced it will stop covering GLP-1 weight-loss medications for its employee health plan, effective July 1. The decision affects drugs such as Novo Nordisk’s Wegovy and Eli Lilly’s Zepboun…
    STAT · 3mo agoRegulatoryNegative↗ source
  • Eli Lilly signs up to $1.9B deal with Ascidian Therapeutics for RNA editing in kidney disease
    Ascidian Therapeutics recently presented early data indicating that its novel RNA‑editing approach to repair faulty genes appears safe in humans, focusing on kidney disease applications. Eli Lilly…
    Endpoints · 3mo agoDealPositive↗ source
  • NIH terminates $82 million outbreak research network, weakening pandemic preparedness
    In 2020 the National Institutes of Health created a network of ten centers to expand knowledge on re‑emerging and emerging infectious diseases. The program was funded with $82 million over five yea…
    STAT · 3mo agoRegulatoryNegative↗ source
  • Trump administration's new Medicaid work-requirement rules surprise states and patients
    Medicaid leaders and advocates say they are shocked by the Trump administration's latest directives that tighten work‑requirement rules for the program, a shift from the tone of earlier federal sta…
    STAT · 3mo agoRegulatoryNegative↗ source
  • NIH scientist and fellow charged with smuggling deactivated mpox virus into U.S.
    Two researchers at a U.S. government laboratory have been indicted for attempting to bring vials of deactivated mpox virus into the United States without proper authorization. The charges involve V…
    STAT · 3mo agoRegulatoryNegative↗ source
  • Alnylam commits $30 million upfront to AI startup Inceptive for RNA research collaboration
    Alnylam Pharmaceuticals announced a new collaboration with Inceptive, a Silicon Valley biotech startup that focuses on RNA. The agreement includes an upfront payment of $30 million and is intended…
    Endpoints · 3mo agoDealPositive↗ source
  • Eli Lilly says its GLP-1 weight loss shot and pill now covered for millions of Americans
    Eli Lilly announced that its GLP-1 based weight-loss injection and oral medication have been added to the formularies of the three largest pharmacy benefit managers. The company said this move make…
    Endpoints · 3mo agoPositive↗ source
  • Mineralys Therapeutics raises funds ahead of pending lorundrostat hypertension approval
    Mineralys Therapeutics first came to market attention in 2021 when it licensed a novel hypertension candidate, lorundrostat, from Japan’s Tanabe Pharma, agreeing to a modest $1 million upfront paym…
    Endpoints · 3mo agoDealNeutral↗ source
  • Pope’s AI Encyclical Offers Guidance for Catholic Hospitals and Health Care
    The article notes that Pope Francis released an encyclical addressing artificial intelligence and examines what that means for Catholic hospitals and the broader health‑care system. STAT’s AI Prog…
    STAT · 3mo agoNeutral↗ source
  • FDA issues new guidance for pharma on discussing unapproved drugs with payors
    The FDA has released guidance aimed at biopharma companies that are preparing to launch new therapies before they receive formal approval. The advice focuses on how companies can inform health-pla…
    Endpoints · 3mo agoRegulatoryNeutral↗ source
  • Bristol Myers Squibb assesses AI spending after deploying tools to thousands of staff
    Bristol Myers Squibb has recently provided artificial intelligence applications to a large portion of its workforce. The company is now turning its attention to measuring the cost of these tools a…
    Endpoints · 3mo agoNeutral↗ source
  • Concerns arise that military practices may contribute to eating disorders amid broader health updates
    The Morning Rounds newsletter, written by Theresa Gaffney, raises a question about whether military environments are encouraging eating disorders. The piece is part of a daily health briefing that…
    STAT · 3mo agoNeutral↗ source
  • Researchers urge sweeping policy action on ultra-processed foods after poll shows bipartisan concern
    A special edition of the American Journal of Public Health brings together leading researchers on ultra-processed foods and delivers a clear message to policymakers: take action now. Food policy s…
    STAT · 3mo agoRegulatoryNeutral↗ source
  • Rising AI battle between hospitals and insurers drives soaring medical bills, says pediatric cardiologist
    Darshak Sanghavi, a pediatric cardiologist and chief medical officer of Machinify, writes an opinion piece about an emerging AI conflict between health providers and insurers over patient records a…
    STAT · 3mo agoNegative↗ source
  • Military culture may increase risk of eating disorders among men, expert warns
    Paula Chesley, a yoga and meditation instructor who works with people with eating disorders, notes that male clients are rare but many have served in the military. She says that, based on her expe…
    STAT · 3mo agoNegative↗ source
  • Public health must address the rapidly growing Amish population, experts say
    The STAT First Opinion podcast highlighted that the Amish community is expanding quickly, roughly doubling every two decades, which will increasingly affect public health planning. Researchers Bra…
    STAT · 3mo agoNeutral↗ source
  • Roche reports narrow failure of breast cancer pill in Phase 3 trial at ASCO
    Roche updated investors and the oncology community that its experimental breast cancer oral therapy did not meet its primary endpoint in a pivotal Phase 3 study. The data, presented at the America…
    Endpoints · 3mo agoNegative readoutNegative↗ source
  • Allen Institute launches multi-hundred-million-dollar effort to turn brain atlas data into neurodegenerative drug candidates
    The Allen Institute, a Seattle nonprofit known for basic brain research, announced a major new effort to move its brain‑atlas knowledge toward drug development. The program will invest several hun…
    Endpoints · 3mo agoPositive↗ source
  • FDA issues draft guidance outlining data flexibilities for cell and gene therapy developers
    The FDA released a draft guidance from its Center for Biologics Evaluation and Research (CBER) that clarifies how developers of cell and gene therapies can use existing data and prior knowledge in…
    Endpoints · 3mo agoRegulatoryNeutral↗ source